Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients

The open-label, phase II clinical trial of antituberculosis therapy (ATT) with or without oral immunomodulator Dzherelo (Immunoxel) was conducted in TB/HIV coinfected, antiretroviral therapy naïve patients to evaluate the effect on CD4 T-lymphocyte counts and viral load. The arm A (n = 20) received...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nikolaeva, Lyudmila G, Maystat, Tatyana V, Masyuk, Lilia A, Pylypchuk, Volodymyr S, Volyanskii, Yuri L, Kutsyna, Galyna A
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2009
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2761183/
https://ncbi.nlm.nih.gov/pubmed/19920896
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados